1. Home
  2. NUS vs RNAC Comparison

NUS vs RNAC Comparison

Compare NUS & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nu Skin Enterprises Inc.

NUS

Nu Skin Enterprises Inc.

HOLD

Current Price

$4.83

Market Cap

266.5M

Sector

Health Care

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.72

Market Cap

238.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUS
RNAC
Founded
1984
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.5M
238.9M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
NUS
RNAC
Price
$4.83
$8.72
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$34.00
AVG Volume (30 Days)
538.1K
104.3K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
3.36%
N/A
EPS Growth
207.80
N/A
EPS
N/A
N/A
Revenue
$3,176,718,000.00
$2,797,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.98
N/A
52 Week Low
$4.49
$5.60
52 Week High
$14.62
$11.77

Technical Indicators

Market Signals
Indicator
NUS
RNAC
Relative Strength Index (RSI) 38.87 56.73
Support Level N/A $8.80
Resistance Level $5.51 $9.27
Average True Range (ATR) 0.23 0.42
MACD -0.04 0.10
Stochastic Oscillator 33.66 91.42

Price Performance

Historical Comparison
NUS
RNAC

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: